Ani Pharmaceuticals (ANIP) Interest Coverage Ratio (2011 - 2026)

Ani Pharmaceuticals (ANIP) has 16 years of Interest Coverage Ratio data on file, last reported at 1.01 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio rose 78.42% year-over-year to 1.01; the trailing twelve-month figure through Mar 2026 stood at 3.21 (up 2200.79% YoY), and the FY2025 full-year result was 2.3, up 20177.63% from the prior year.
• Interest Coverage Ratio fell to 1.01 in Q1 2026, from 3.39 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 3.39 in Q4 2025 to a low of 0.85 in Q4 2024.
• A 5-year average of 0.45 and a median of 0.43 in 2023 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio plunged 612.83% in 2022 and jumped 630.63% in 2023, its largest moves.
• Tracing ANIP's Interest Coverage Ratio over 5 years: stood at 0.24 in 2022, then jumped by 125.5% to 0.55 in 2023, then slumped by 254.39% to 0.85 in 2024, then soared by 499.0% to 3.39 in 2025, then plunged by 70.29% to 1.01 in 2026.
• Business Quant data shows ANIP's Interest Coverage Ratio at 1.01 in Q1 2026, 3.39 in Q4 2025, and 0.75 in Q3 2025.